Takeda

Several gastrointestinal diseases and disorders in humans remain poorly understood and inadequately treated. Irritable bowel syndrome, abdominal pain, chronic itch, severe constipation and diarrhoea are examples of some of the common and debilitating disorders that afflict millions of people worldwide.

Through a strategic alliance, Monash Institute of Pharmaceutical Sciences (MIPS) and Takeda scientists worked together to research the mechanisms that underlie some of the common and debilitating GI disorders.

The innovation journey has seen several technological licences leading to powerful therapies for digestive and sensory diseases.

Website: takeda.com